Jim Simons Minerva Neurosciences, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 177,765 shares of NERV stock, worth $567,070. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177,765
Previous 107,200
65.83%
Holding current value
$567,070
Previous $659,000
30.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NERV
# of Institutions
21Shares Held
2.1MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$4.31 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$804,0710.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL99.6KShares$317,8640.02% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$231,8140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA52.6KShares$167,7680.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $17M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...